QL
RVMD icon

Quarry LP’s Revolution Medicines RVMD Stock Holding History

Quarry LP’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.52M Sell
40,175
-19,088
-32% -$2.79M 0.63% 17
2026
Q1 		$5.76M Buy
+59,263
New +$5.98M 1.03% 22
2025
Q2 		– Sell
-1,400
Closed -$49.5K – 2007
2025
Q1 		$49.5K Buy
+1,400
New +$56.8K 0.01% 805
2024
Q4 		– Sell
-1,800
Closed -$81.6K – 1957
2024
Q3 		$81.6K Buy
+1,800
New +$78.4K 0.02% 504
2024
Q2 		– Sell
-1,700
Closed -$54.8K – 2054
2024
Q1 		$54.8K Buy
+1,700
New +$50.4K 0.01% 425

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Quarry LP's RVMD Position: Q2 2026 in Review

Quarry LP reduced its Revolution Medicines (RVMD) stake by 32% in Q2 2026, selling an estimated $2.79M and leaving 40,175 shares worth $7.52M. The position accounts for 0.63% of the portfolio, ranked #17.

Quarry LP first reported a position in RVMD in Q1 2024 and has held it in 5 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Quarry LP held 40,175 shares of Revolution Medicines worth $7.52M as of Q2 2026.
  • Quarry LP sold 19,088 Revolution Medicines shares in Q2 2026, an estimated $2.79M.
  • Revolution Medicines made up 0.63% of Quarry LP's portfolio in Q2 2026, its #17 holding.
  • Quarry LP first reported a position in Revolution Medicines in Q1 2024 and has held it in 5 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.